Filing Details

Accession Number:
0001225208-25-002655
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-03 16:11:53
Reporting Period:
2025-02-28
Filing Date:
2025-03-03
Accepted Time:
2025-03-03 16:11:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2013518 Emily Woodworth 300 Boston Scientific Way
Marlborough MA 01752-1234
Svp, Global Controller And Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-28 7,218 $42.16 11,519 No 4 M Direct
Common Stock Disposition 2025-02-28 9,887 $101.13 1,632 No 4 S Direct
Common Stock Acquisiton 2025-03-01 837 $0.00 2,469 No 4 M Direct
Common Stock Disposition 2025-03-01 355 $103.79 2,114 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2025-02-28 7,218 $0.00 7,218 $42.16
Common Stock Restricted Stock Units Disposition 2025-03-01 837 $0.00 837 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2030-02-18 No 4 M Direct
2,514 2028-03-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
  2. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  3. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
  4. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.